Copyright © 2007, The European Society of Cardiology
Tissue Doppler Imaging in the assessment of selection and response from cardiac resynchronization therapy
aCardiac Department, "La Sapienza" University, Via Lima 35, 00198 Rome, Italy
bCardiac Department, The University of Texas, Galveston, TX, USA
Received 25 October 2006; received in revised form 29 November 2006; accepted after revision 15 December 2006.
vitar{at}tiscali.it
* Corresponding author. Tel.: +39 6 8530 1427; fax: +39 6 884 1926.
| Abstract |
|---|
|
|
|---|
Mechanistic studies, observational evaluations, and randomized trials have consistently demonstrated the beneficial effects of cardiac resynchronization therapy (CRT) in patients with moderate-to-severe chronic systolic heart failure and ventricular dyssynchrony who have failed optimal medical treatment. However, despite the promising results, in some patients undergoing CRT, the symptoms of heart failure do not improve or even worse. One of the most important reasons for this failure is probably the lack of distinct mechanical dyssynchrony before implantation. This review discusses the actual and potential role of Tissue Doppler Imaging in selection of patients and optimisation of CRT.
Keywords: Heart failure; Resynchronization therapy; Echocardiography; Tissue Doppler Imaging
| Introduction |
|---|
|
|
|---|
Cardiac resynchronization therapy (CRT) with simultaneous right ventricular (RV) and left (LV) ventricular stimulation is a promising therapeutic option in patients with severe heart failure and left bundle branch block. Recently updated ACC/AHA/NASPE pacemaker and ICD guidelines included CRT as a class IIA recommendation for pacing.1 Several trials2 have demonstrated that CRT significantly improved acute hemodynamics, symptoms, exercise tolerance, and quality of life in patients with dilated cardiomyopathy. Still, since some patients do not respond to CRT, the need for additional selection criteria to identify potential responders has been suggested besides electrical dyssynchrony and new imaging modalities, in particular various echocardiographic approaches, have been described.
| Non-responder patients |
|---|
|
|
|---|
Optimal hemodynamic response from resynchronization will depend on several factors such as the mode of implant (LV stimulation, optimisation of the AV interval, RV/LV timing, chronotropic incompetence), the etiology of heart failure (presence or absence of non-viable scar tissue), or the accurate information on ventricular dyssynchrony. Clinical predictors of lack of improvement in patients receiving CRT have been identified. In logistic regression analysis, independent predictors of lack of response to treatment were ischemic heart disease, severe mitral regurgitation, and left ventricular end-diastolic diameter
75mm. If the patient obtains subjective and objective clinical improvement after implantation of a resynchronization device, worsening of the patient's heart failure symptoms suggests worsening of the primary pathologic process or loss of resynchronization, or both.
Non-responder patients have been defined as those who died of heart failure, underwent heart transplantation, did not increase the distance walked in 6min
10%, or did not increase LVEF
25% having lack of reverse left ventricular remodeling (decrease in volumes). The percentage of non-responding patients to CRT as indexed by clinical symptoms or objective evidence of the absence of reverse chamber remodeling is 25% to 30% of recipients. The major entry criteria to date have been the presence of severe dilated heart failure (LVEF
0.35, NYHA class III or IV symptoms despite pharmacological therapy), sinus rhythm, and evidence of a conduction delay on the electrocardiogram as reflected by widening of the QRS complex (
120ms). However, the correlation between QRS duration and acute mechanical response to CRT is modest, and in many chronic studies QRS duration has been a poor predictor of the CRT response. Since narrow QRS complex patients exist who benefit from CRT so long as they have dyssynchronous LV contraction, it appears that analysis of mechanical dyssynchrony is a better predictor of outcome than electrical dyssynchrony (QRS duration).
| TDI technique |
|---|
|
|
|---|
Although the cardiac mechanics related to multisite stimulation are only partially understood, echocardiography has emerged as a test of choice in the selection of candidates for this new treatment. There are several ways of assessing ventricular dyssynchrony using echocardiography. Tissue Doppler Imaging (TDI) allows the assessment of peak systolic velocity of different regions of the myocardium.3–8 Precise timing of peak systolic velocity is possible when the TDI tracings are related to the electrical activity (QRS complex). Integration of this information allows accurate assessment of electromechanical coupling, and evaluation of inter- and intraventricular dyssynchrony.
Interventricular dyssyncrony refers to a prolonged delay between the onset of RV and LV activation. Pulmonary pre-ejection delay can be measured as the time from QRS onset to the start of pulmonary blood flow. The difference between aortic and pulmonary pre-ejection times provides a measure of interventricular mechanical delay and is considered abnormal with values greater than 40ms.3 TDI can also be used to evaluate interventricular dyssyncrony by placing sample volumes in RV basal free wall and LV basal septal and lateral walls and determining the time difference in the onset of RV–LV walls mechanical activation.4–6 However, whether assessment of interventricular dyssynchrony is an effective tool to predict a positive response to CRT remains to be determined.
Intraventricular dyssynchrony is the predominant defect to be corrected by CRT. Tissue Doppler velocities may be displayed either as a spectral pulse or in color encoded two-dimensional or M-mode. Regional electromechanical delays can be measured (Fig. 1) from QRS onset to either the start or peak systolic shortening (S wave). It can be simply used to measure the delay between septal and either the posterior or lateral wall as a guide to intraventricular dyssynchrony, but this assumes the septum to be the earliest site of contraction and the posterior or lateral wall the latest. A more accurate assessment of the dispersion of intraventricular contraction can be calculated by analysing differences between all the different regions (intraventricular dyssynchrony by multiple segmental models) since LV models which assess more segments are more powerful than those that assess a smaller number of segments.9
|
Early diastolic (E) velocities can also be measured (Fig. 1). The time intervals of Q wave to peak S and Q to peak E at each site may be determined and the maximal difference of Q–S or Q–E between sites measures LV systolic and diastolic dyssynchrony, respectively. Despite significant improvement in LV systolic dyssynchrony, significant improvements in LV diastolic function have been observed after CRT only in patients with non-ischemic cardiomyopathy.10
A novel approach, known as tissue synchronization imaging (TSI), extends the concept of time-to-peak velocity as a marker for dyssynchrony by adding color coding (Fig. 2). TSI can characterize the baseline dyssynchrony that is predictive of an acute response to CRT. A
65ms difference in time-to-peak velocity from the anteroseptal to the posterior wall using the apical long-axis view was greatly associated with immediate improvement in LV stroke volume.11 These data are consistent with previous reports of the anteroseptal region being the earliest and the posterior wall being the latest activated site with typical left bundle branch block. This study dealt with Doppler stroke volume to assess acute response to CRT; however, the degree of long-term response supported by long-term data with a larger patient population needs to be addressed.
|
A high predictive value for a positive response to CRT by TSI has been recently reported12 when the time to peak tissue velocity (Ts) was measured in ejection phase only, in particular when 12 (rather than 6) LV segments were analysed. The pre-installation of equations to compare various parameters of asynchrony and the advancement of computer hardware may allow to measure Ts of 12 segments from apical views within a few minutes and calculate Ts-12 automatically.
One limitation of TDI is that it does not distinguish between active and passive wall motion. This has led to the development of the TDI derived modalities of strain rate imaging (SRI), strain (
) and tissue tracking (TT) analysis (Fig. 3). SRI13–17 measures the rate of regional myocardial deformation, and integration of the regional strain rate curve enables the computation of myocardial shortening and lengthening (i.e., estimation of myocardial strain). Bundle branch block can lead to a significant redistribution of abnormal myocardial fiber strains, and these abnormal changes in the extent and timing of septal-lateral strain relationships can be reversed by CRT.13 SRI has also been used before CRT to confirm true shortening in regions showing delayed longitudinal contraction (better known as post-systolic shortening), although strain rate based shortening/elongation information does not necessarily imply viability but can reflect passive phenomena.14,15 It has been shown16 that the greater the number of segments displaying post-systolic shortening, the more severe the degree of dyssynchrony, and this was found to be predictive of short term efficacy of CRT. TT18 visualises the longitudinal motion amplitude in each myocardial segment during systole in a color coded format and can be used in addition to SRI to determine the extent of myocardium with delayed longitudinal contraction. However, myocardial motion velocities and deformation parameters are low in patients with advanced systolic heart failure, which complicates the identification of peak systolic motion and deformation and makes the results susceptible to artifacts and errors. Furthermore, the benefit of not being affected by translational movement may be offset by the relatively large interobserver and intraobserver variability. Technical improvements are required to make SRI data analysis easier and applicable for routine clinical use.
|
| Clinical applications |
|---|
|
|
|---|
Cardiac resynchronization therapy has been shown to improve hemodynamics, quality of life, and VO2 max in both acute and chronic studies of patients with ischemic or idiopathic dilated cardiomyopathy, low ejection fraction and prolonged QRS duration.19–21 Various clinical trials have addressed these issues.2 Resynchronization of systole can also be achieved for patients with conduction abnormalities other than left bundle branch block or patients with normal QRS duration who present with dyssynchronous contraction.3
CRT acts to limit disease progression even in patients with mild heart failure symptoms.22 In optimally treated patients with mildly symptomatic NYHA class II heart failure, a wide QRS complex, and an ICD indication, CRT significantly improved cardiac structure and function and a composite clinical response measure over a 6-month period of follow-up. CRT produced significant improvement in LV systolic and diastolic volumes and LVEF, even if these effects did not translate into improved exercise capacity. However, these observations must be confirmed by future randomised controlled trials of mildly symptomatic heart failure patients before the indication for resynchronization therapy is extended to this population.
As opposed to population with ischemic chronic heart failure and LBBB, patients with congenital heart disease often demonstrate right ventricular conduction delay or RBBB, especially after ventricular surgery. This electrical disturbance is often associated with acute postoperative reduction of RV performance or chronic RV dysfunction due to residual defects such as pulmonary regurgitation as a result of previous surgeries or multiple previous procedures. Thus, RV dysfunction such as assessed by Tissue Doppler Imaging appears to be a reasonable therapeutic target in post-operative congenital heart disease. Issues specific to congenital heart disease include right bundle branch block, right (pulmonary) ventricular dysfunction, systemic right ventricular dysfunction, and single ventricle dysfunction.23,24
The use of multisite pacing as adjunctive therapy during weaning from cardiopulmonary by-pass has been reported in adults and children. This practice in the immediate postoperative period is appealing because may avoid some of the unwanted side effects of increasing doses of inotropic agents used to support cardiac function. It has been described25 an improved cardiac index and systolic blood pressure in postoperative patients with univentricular or biventricular anatomy and bundle branch block or interventricular conduction delay. Hemodynamic benefit of multisite RV pacing was similar to what has been reported in CAD or DCM patients with low ejection fraction. Cardiac index was calculated either with Fick equation or Doppler aortic data. Similar hemodynamic results using electrical resynchronization have been reported in patients with tetralogy of Fallot and RV dysfunction determined by echocardiography or angiocardiography.
Beneficial changes in systolic and diastolic RV function using TDI and strain Doppler have been documented after biventricular pacing in patients with post-operative transposition of the great arteries and either spontaneous or pacing-induced RV desynchronization.26 CRT was associated with improved RV +dP/dt, fractional area change, and NYHA functional classification in the mid-term. Interventricular mechanical delay decreased and RV contraction synchrony improved. However, tricuspid valve regurgitation did not decrease following CRT in a similar way as functional mitral regurgitation. Thus, concurrent tricuspid valve interventions may be a necessary adjunct to CRT in patients with severe regurgitation but may be facilitated by the improvement in RV function achieved by resynchronization. A criticism was raised by the same authors regarding the inclusion in the resynchronization therapy of some patients with marginally decreased RV function who underwent "preventive" CRT at the occasion of other necessary cardiac surgery.
In congenital heart disease the heterogeneous patient population, technical limitations in pediatric patients, vascular access issues, and unique forms of ventricular asynchrony often obscure the selection of potential CRT beneficiaries. Despite these limitations, initial results are optimistic and experience thus far has been favorable.
| Patients selection and management |
|---|
|
|
|---|
Tissue Doppler Imaging is one of the most promising techniques for guiding patient selection. Ventricular asynchrony has a high prevalence in patients with LV dysfunction but there is poor agreement among the different methods available for detecting asynchrony.27 Various echocardiographic and TDI parameters have been reported in the recent literature. A recently developed "St Mary's protocol"28 provides a high probability of dyssynchrony and identifies patients likely to benefit from CRT. By applying this protocol, it was found that 88% of patients had benefited symptomatically with a reduction in New York Heart Association (NYHA) functional class. Selection for biventricular pacing required the presence of two major criteria (TDI intraventricular dyssynchrony >55ms, intraventricular+interventricular dyssynchrony >100ms), or one major and three minor criteria, or four minor criteria (TDI intraventricular dyssynchrony >40ms, interventricular dyssynchrony >40ms, DFT <40% cardiac cycle, LVPEP >140ms, QRS >130ms).
TDI can be used to guide the management of patients with systolic heart failure (Fig. 4). Patients with drug-refractory HF should undergo a TDI study to quantitate LV ejection fraction and dyssynchrony. In the presence of LVEF <35%, an ICD should be implanted (no dyssynchrony) or CRT+ICD should be performed (significant dyssynchrony). Non-responder patients could have a TDI pacemaker optimisation study to check possible hemodynamic improvements after changes in PM settings.
|
| Site optimisation |
|---|
|
|
|---|
Echo-Doppler methods can also be used in optimising biventricular pacing. Preliminary evidence suggests that optimal improvements in LV performance may be achieved when pacing at the most delayed site.29,30 TDI enables identification of the site of delayed LV contraction and may be useful in guiding LV lead placement at implantation,31 even if the site of LV pacing is often limited by individual coronary venous anatomy.
The optimisation of AV delay following pacemaker implantation has traditionally been achieved using Doppler echocardiography. Alternatively, the AV delay can be programmed, guided by the aortic velocity time integral (VTI) with the maximum VTI recorded being defined as the optimal AV delay.
In more advanced biventricular pacemakers it is now possible to alter the interventricular pacing interval (IVPI), to allow either LV or RV preactivation. The IVPI can be adjusted to provide the maximal forward stroke volume as measured by the aortic VTI; however, more research is required in this area.
| Assessment of benefits |
|---|
|
|
|---|
It has been shown that biventricular pacing can result in reverse remodeling in patients with advanced heart failure,32–34 and these changes are associated with improvement in systolic function, increase in LVEF, decrease in LV volumes, reduction of mitral regurgitation, and increase in diastolic filling time. The benefits are attributable to an improvement in intraventricular and interventricular synchrony as well as to a shortening of isovolumic contraction time.
Although these beneficial findings may be associated with a reduction in mitral regurgitation (MR) after CRT, a clear distinction has not been defined between immediate MR reduction and remote decreases secondary to reverse remodelling of the LV, which takes from weeks to months to occur. The immediate reduction in MR after CRT has been quantified and associated with the coordinated mechanical activation of papillary muscle insertion sites.35 A delay in peak strain at the mid lateral segment adjacent to the anterolateral papillary muscle has been observed, implying tethering of the mitral leaflet, which was improved immediately after CRT. CRT appeared to coordinate the tethering forces on the papillary muscles and increase the leaflet coaptational surface to reduce MR.
Other mechanisms of decreased MR after CRT as assessed by color jet area have previously been attributed to decreases in LV size from reverse remodelling.2,36 However, color jets are considerably affected by numerous factors: transducer frequency, gain, Nyquist limit, frame rate, jet eccentricity, and flow momentum, which is the product of flow rate and velocity. The degree of MR has also been assessed using the proximal isovelocity surface area method,16 which uses both color and spectral Doppler data, during both pacing-off and CRT in the first week after CRT and a correlation has been shown with the reduction in isovolumic contraction time.
Promising data suggest the possibility of effective quantification of papillary muscle contractile function using maximum strain (
max) measurements derived from TDI, which theoretically are not affected by the tethering effect and contractile function of adjacent myocardial wall.37–39 It has been shown that, in addition to increased closing force and papillary muscles recoordinated contraction described as main determinants of attenuation of functional MR, CRT may acutely reduce MR severity by improving systolic deformation of the papillary muscles or adjacent myocardial wall.39 The overall improved strain in more spherical ventricles, together with an increased mean negative strain in the basal segments initiated by CRT, may relieve apical tenting of the mitral leaflets by reducing tethering of papillary muscles.
Sustained effects at longer follow-up after CRT in patients with both symptomatic and mildly symptomatic heart failure need to be confirmed in future studies.
| References |
|---|
|
|
|---|
- Gregoratos G., Abrams J., Epstein A.E., Freedman R.A., Hayes D.L., Hlatky M.A., et al. ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation (2002) 106:2145–2161.
[Free Full Text] - Coletta A., Cleland J.G., Freemantle N., Clark A.L. Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. Eur J Heart Fail (2004) 6:673–676.
[Abstract/Free Full Text] - Bax J.J., Abraham T., Barold S.S., Breithardt O.A., Fung J.W., Garrigue S., et al. Cardiac resynchronization therapy: Part 1–issues before device implantation. J Am Coll Cardiol (2005) 46:2153–2167.
[Abstract/Free Full Text] - Vitarelli A., Franciosa P., Conde Y., Cimino E., Nguyen B.L., Ciccaglione A., et al. Echocardiographic assessment of ventricular asynchrony in dilated cardiomyopathy and congenital heart disease: tools and hopes. J Am Soc Echocardiogr (2005) 18:1424–1439.[CrossRef][Web of Science][Medline]
- Bleeker G.B., Bax J.J., Schalij M.J., van der Wall E.E. TDI to assess left ventricular dyssynchrony and resynchronization therapy. Eur J Echocardiogr (2005) 12:154–162.
- Bank A.J., Kelly A.S. Tissue Doppler imaging and left ventricular dyssynchrony in heart failure. J Card Fail (2006) 12:154–162.[CrossRef][Web of Science][Medline]
- Yu C.M., Zhang Q., Chan Y.S., Chan C.K., Yip G.W., Kum L.C., et al. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Heart (2006) 92:1452–1456.
[Abstract/Free Full Text] - Westenberg J.J., Lamb H.J., van der Geest R.J., Bleeker G.B., Holman E.R., Schalij M.J., et al. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging. J Am Coll Cardiol (2006) 47:2042–2048.
[Abstract/Free Full Text] - Yu C.M., Fung J.W., Zhang Q., Chan C.K., Chan Y.S., Lin H., et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation (2004) 110:66–73.
[Abstract/Free Full Text] - Waggoner A.D., Rovner A., de las Fuentes L., Faddis M.N., Gleva M.J., Sawhney N., et al. Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure. J Am Soc Echocardiogr (2006) 19:307–313.[CrossRef][Web of Science][Medline]
- Gorcsan J., Kanzaki H., Bazaz R., Dohi K., Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol (2004) 93:1178–1181.[CrossRef][Web of Science][Medline]
- Yu C.M., Zhang Q., Fung J.W., Chan C.K., Chan Y.S., Yip G.W., et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol (2005) 45:677–684.
[Abstract/Free Full Text] - Breithardt O.A., Stellbrink C., Herbots L., Claus P., Sinha A.M., Bijnens B., et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J Am Coll Cardiol (2003) 42:486–494.
[Abstract/Free Full Text] - Skulstad H., Urheim S., Edvardsen T., Andersen K., Lyseggen E., Vartdal T., et al. Grading of myocardial dysfunction by tissue Doppler echocardiography: a comparison between velocity, displacement, and strain imaging in acute ischemia. J Am Coll Cardiol (2006) 47:1672–1682.
[Abstract/Free Full Text] - Skulstad H., Edvardsen T., Urheim S., Rabben S.I., Stugaard M., Lyseggen E., et al. Postsystolic shortening in ischemic myocardium. Active contraction or passive recoil? Circulation (2002) 106:718–724.
[Abstract/Free Full Text] - Breithardt O.A., Stellbrink C., Kramer A.P., Sinha A.M., Franke A., Salo R., et al. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol (2002) 40:536–545.
[Abstract/Free Full Text] - Dohi K., Suffoletto M.S., Schwartzman D., Ganz L., Pinsky M.R., Gorcsan J. 3rd. Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. Am J Cardiol (2005) 96:112–116.[CrossRef][Web of Science][Medline]
- Pan C., Hoffmann R., Kuhl H., Severin E., Franke A., Hanrath P. Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiogr (2001) 2:197–202.
[Abstract/Free Full Text] - Kang S.J., Song J.K., Song J.M., Kang D.H., Lee E.Y., Kim J., et al. Usefulness of ventricular longitudinal contractility assessed by Doppler tissue imaging in the prediction of reverse remodeling in patients with severe left ventricular systolic dysfunction. J Am Soc Echocardiogr (2006) 19:178–184.[CrossRef][Web of Science][Medline]
- Rosanio S., Schwarz E.R., Ahmad M., Jammula P., Vitarelli A., Uretsky B.F., et al. Benefits, unresolved questions and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol (2005) 96:710–717.[CrossRef][Web of Science][Medline]
- Bleeker G.B., Kaandorp T.A., Lamb H.J., Boersma E., Steendijk P., de Roos A., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation (2006) 113:969–976.
[Abstract/Free Full Text] - Bleeker G.B., Schalij M.J., Holman E.R., Steendijk P., van der Wall E.E., Bax J.J., et al. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2006) 98:230–235.[CrossRef][Web of Science][Medline]
- Abd El Rahman M.Y., Hui W., Yigitbasi M., Dsebissowa F., Schubert S., Hetzer R., et al. Detection of left ventricular asynchrony in patients with right bundle branch block after repair of tetralogy of Fallot using tissue Doppler imaging-derived strain. J Am Coll Cardiol (2005) 45:915–921.
[Abstract/Free Full Text] - Dubin A.M., Janousek J., Rhee E., Strieper M.S., Cecchin F., Law I.H., et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol (2005) 46:2277–2283.
[Abstract/Free Full Text] - Bacha E.A., Zimmerman F., Mor-Avi V., Weinert L., Starr J.P., Sugeng L., et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg (2004) 78:1678–1683.
[Abstract/Free Full Text] - Janou
ek J., Tomek V., Chaloupecky V., Reich O., Gebauer R.A., Kautzner J., et al. Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol (2004) 44:1927–1931.[Abstract/Free Full Text] - Perez de Isla L., Florit J., Garcia-Fernandez M.A., Evangelista A., Zamorano J. Prevalence of echocardiographically detected ventricular asynchrony in patients with left ventricular systolic dysfunction. J Am Soc Echocardiogr (2005) 18:850–859.[CrossRef][Web of Science][Medline]
- Lane R.E., Chow A.W., Chin D., Mayet J. Selection and optimisation of biventricular pacing; the role of echocardiography. Heart (2004) 90(Suppl. IV):vi10–vi16.
[Abstract/Free Full Text] - Bax J.J., Ansalone G., Breithardt O.A., Derumeaux G., Leclercq C., Schalij M.J., et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? J Am Coll Cardiol (2004) 44:1–9.
[Abstract/Free Full Text] - Jansen A.H., Bracke F., van Dantzig J.M., Meijer A., Korsten E.H., Peels K.H., et al. Optimization of pulsed wave tissue Doppler to predict left ventricular reverse remodeling after cardiac resynchronization therapy. J Am Soc Echocardiogr (2006) 19:185–191.[CrossRef][Web of Science][Medline]
- Dohi K., Suffoleto M., Ganz L., Zenati M., Gorcsan J. Utility of echocardiographic tissue synchronization imaging to redirect left ventricular lead placement for improved cardiac resynchronization therapy. Pacing Cin Electrophysiol (2005) 28:461–465.[CrossRef]
- Steendijk P., Tulner S.A., Bax J.J., Oemrawsingh P.V., Bleeker G.B., van Erven L., et al. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation (2006) 113:1295–1304.
[Abstract/Free Full Text] - Bleeker G.B., Schalij M.J., Nihoyannopoulos P., Steendijk P., Molhoek S.G., van Erven L., et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol (2005) 46:2264–2269.
[Abstract/Free Full Text] - Vitarelli A., Franciosa P., Conde Y., Cimino E., Nguyen B.L., D'Orazio S., et al. Effects of cardiac resynchronization therapy on left as well as right ventricular deformation parameters. J Card Fail (2006) 12(Suppl.):216.
- Kanzaki H., Bazaz R., Schwartzmann D., Dohi K., Sade L.E., Gorcsan J. 3rd. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 44:1619–1625.
[Abstract/Free Full Text] - Yu C.M., Chau E., Sanderson J.E., Fan K., Tang M.O., Fung W.H., et al. Tissue Doppler echocardiographic evidence of reverse remodelling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation (2002) 105:438–445.
[Abstract/Free Full Text] - Nof E., Glikson M., Bar-Lev D., Gurevitz O., Luria D., Eldan M., et al. Mechanism of diastolic mitral regurgitation in candidates for cardiac resynchronization therapy. Am J Cardiol (2006) 97:1611–1614.[CrossRef][Web of Science][Medline]
- Cappola T.P., Harsch M.R., Jessup M., Abraham W.T., Young J.B., Plappert T., et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. J Card Fail (2006) 12:182–188.[CrossRef][Web of Science][Medline]
- Karvounis H.I., Dalamaga E.G., Papadopoulos C.E., Karamitsos T.D., Vassilikos V., Paraskevaidis S., et al. Improved papillary muscle function attenuates functional mitral regurgitation in patients with dilated cardiomyopathy after cardiac resynchronization therapy. J Am Soc Echocardiogr (2006) 19:1150–1157.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
O. I.I. Soliman, M. L. Geleijnse, and F. J. ten Cate Echocardiographic selection of candidates for cardiac resynchronization therapy: the lack of evidence! Eur J Echocardiogr, May 1, 2008; 9(3): 319 - 320. [Full Text] [PDF] |
||||
![]() |
A. Vitarelli Echocardiographic selection of candidates for cardiac resynchronization therapy: the lack of evidence! Reply Eur J Echocardiogr, May 1, 2008; 9(3): 320 - 321. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




